Identification of mutations common to half of all liver cancers provides leads for new therapeutics

November 16, 2012
Some 50% of liver cancer tumors carry mutations in a gene that encodes chromatin regulators. Credit:

Liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer-associated deaths. Yet even for such a frequent and deadly disease, the pathogenesis of this cancer remains obscure. Now, a team of scientists in Japan has shown that genes involved in regulating how tightly DNA is wound into chromosomes are commonly mutated in liver tumors. The finding points to potential new and much-needed therapeutic strategies.

"Several types of drugs under development target chromatin regulators, and these drugs may be effective in liver cancer," says Hidewaki Nakagawa, a cancer geneticist at the RIKEN Center for Genomic Medicine in Yokohama, who led the work.

Nakagawa and his colleagues decoded the entire genomes of liver tumors from 27 different patients—25 of whom carried hepatitis viruses, the most common cause of liver cancer, and two without associated infections. They also sequenced the DNA of matched healthy for comparison.

No two cancers were alike, even when the researchers analyzed the whole genomes of pairs of liver cancers that arose independently in the same individual—not from metastasis. "Their whole genomic alterations were completely different and independent, indicating heterogeneity of liver cancers in the same patient," Nakagawa says.

Some striking patterns emerged. Across all 27 cancer genomes, the researchers discovered more than 2,000 protein-altering mutations, with frequent alterations occurring in 15 different genes—many of which affect chromatin, the mass of DNA and proteins that condense to form chromosomes and affect . Notably, 14 of the 27 tumors had mutations in at least one chromatin . In cell culture, lacking these genes displayed a marked increase in cell proliferative capacity. " in chromatin regulators can regulate and produce epigenetic alterations in cancer," Nakagawa explains.

The findings are consistent with those reported last year by an independent group that showed that ARID2, a chromatin remodeling gene also implicated by Nakagawa and his team, was mutated in six of the 33 liver cancers considered.

In addition to chronicling the mutational profile, Nakagawa and his colleagues determined where hepatitis B-associated tumors had the viruses inserted into their genomes. Consistent with independent findings reported in the same issue of Nature Genetics, in four of the 11 relevant cancers they found viral integration within or near the TERT gene, which is involved in maintaining the caps on the end of chromosomes. Targeting the TERT locus, therefore, offers another therapeutic drug lead for this nasty cancer.

Explore further: Pinpointing a tell-tale mark of liver cancer

More information: Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K.A., Hosoda, F., Nguyen, H.H., Aoki, M., Hosono, N., Kubo, M., Miya, F., et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nature Genetics 44, 760–764 (2012).

Li, M., Zhao, H., Zhang, X., Wood, L.D., Anders, R.A., Choti, M.A., Pawlik, T.M., Daniel, H.D., Kannangai, R., Offerhaus, G.J., et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nature Genetics 43, 828–829 (2011).

Sung, W.K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N.P., Lee, W.H., Ariyaratne, P.N., Tennakoon, C., et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.Nature Genetics44, 765–769.

Related Stories

Pinpointing a tell-tale mark of liver cancer

July 8, 2011
Persistent hepatitis C virus (HCV) infection can lead to chronic hepatitis C and then progress to fatal liver diseases including liver cirrhosis and liver cancer, the third most common cause of cancer-related deaths. Worldwide, ...

Research discovers frequent mutations of chromatin remodeling genes in TCC of the bladder

August 7, 2011
BGI, the world's largest genomics organization, Peking University Shenzhen Hospital and Shenzhen Second People's Hospital, announced today that the study on frequent mutations of chromatin remodeling genes in transitional ...

Team genetically sequences most common bladder cancer

August 11, 2011
In an article published online this week in Nature Genetics, a University of Colorado Cancer Center team in partnership with universities in China and Denmark reports the first genetic sequencing of urothelial (transitional) ...

Lung tumors in never-smokers show greater genomic instability than those in smokers

July 5, 2011
Lung adenocarcinomas in people who have never smoked show greater genome instability than those in smokers, supporting the theory that lung cancer in never smokers arises through different pathways, according to research ...

Researchers identify novel genes that may drive rare, aggressive form of uterine cancer

October 28, 2012
Researchers have identified several genes that are linked to one of the most lethal forms of uterine cancer, serous endometrial cancer. The researchers describe how three of the genes found in the study are frequently altered ...

Recommended for you

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

Suicide molecules kill any cancer cell

October 19, 2017
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.